Status:
COMPLETED
12 Weeks Vitamin D Supplementation and Physical Activity in PD Patients With DBS
Lead Sponsor:
Medical University of Gdansk
Conditions:
Vitamin D Deficiency
Parkinson Disease
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is the second most frequently appearing neurodegenerative disease. It is a progressive disease of the central nervous system (CNS) and affects around 1% of people over 60 year...
Detailed Description
Participants will be divided randomly into 2 groups: a control group and supplemented group. Supplementation will last for 12 weeks. Supplementation of vitamin D3 will be based on the participants B...
Eligibility Criteria
Inclusion
- agreement to take part in a research,
- Subthalamic nucleus deep brain stimulation (STN-DBS) treatment,
- willingness to work.
Exclusion
- supplementation of vitamin D before the research,
- serious comorbidity (like tumour, cerebrovascular disease, cardiorespiratory compromise, forced dementia).
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04768023
Start Date
November 1 2019
End Date
February 28 2022
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Gdansk
Gdansk, Poland